OneSource Specialty Pharma Limited has scheduled its earnings call for Saturday, January 24, 2026, at 09:30 AM IST to discuss the company's unaudited financial results for the quarter ended December 31, 2025. The pharmaceutical company announced this development through a regulatory filing dated January 19, 2026.

Earnings Call Schedule

The earnings call has been organized to provide analysts and investors with insights into the company's Q3FY26 performance. The call will be conducted on a Saturday morning, allowing participants to engage with the senior management team regarding the quarterly financial results.

Management Participation

The earnings call will feature key members of OneSource Specialty Pharma's senior management team who will interact with participants and address queries related to the company's quarterly performance.

Senior Management Speakers:

• Arun Kumar, Founder & Non-Executive Chairperson
• Neeraj Sharma, CEO & MD
• Anurag Bhagania, CFO

Conference Call Access Details

The company has provided multiple access options for participants to join the earnings call. Analysts and investors can use the universal access numbers or register early through the DiamondPass registration system.

Regulatory Compliance

The earnings call announcement was made in compliance with Regulation 30 of the Securities and Exchange Board of India (SEBI) regulations. The communication was signed by Trisha A, Company Secretary and Compliance Officer (Membership Number: A47635), ensuring proper regulatory adherence for the scheduled investor interaction.

OneSource Specialty Pharma Limited has announced that its Board of Directors will convene on January 23, 2026, to review and approve the company's unaudited financial results for the third quarter of fiscal year 2026. The meeting is scheduled in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Meeting Agenda and Financial Review

The board meeting will focus on considering and approving both standalone and consolidated unaudited financial results for the quarter ended December 31, 2025. The company has indicated that other matters may also be discussed during the session, though specific details of additional agenda items have not been disclosed.

Trading Window Restrictions

In accordance with the company's Code of Conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015, OneSource Specialty Pharma has implemented trading restrictions for designated persons. The trading window closure became effective from January 1, 2026, and will remain in place until 48 hours after the company disseminates its financial results to the public.

Regulatory Compliance

The announcement demonstrates the company's adherence to regulatory requirements under SEBI listing regulations. The formal notification was signed by Trisha A, Company Secretary and Compliance Officer (Membership Number: A47635), and submitted to both major stock exchanges where the company's shares are listed.

The company has requested both BSE Limited and National Stock Exchange of India Ltd to take this information on record, ensuring proper disclosure to market participants and investors ahead of the financial results announcement.